Seminars in Radiation Oncology
Volume 17, Issue 2 , Pages 72-80 , April 2007

The Role of Functional Imaging in the Diagnosis and Management of Late Normal Tissue Injury

  • Elizabeth S. Evans, BS

      Affiliations

    • Department of Radiation Oncology, Duke University Medical Center, Durham, NC.
    • ,
  • Carol A. Hahn, MD

      Affiliations

    • Department of Radiation Oncology, Duke University Medical Center, Durham, NC.
    • ,
  • Zafer Kocak, MD

      Affiliations

    • Department of Radiation Oncology, Trakya University Hospital, Edirne, Turkey.
    • ,
  • Su-Min Zhou, PhD

      Affiliations

    • Department of Radiation Oncology, Duke University Medical Center, Durham, NC.
    • ,
  • Lawrence B. Marks, MD

      Affiliations

    • Department of Radiation Oncology, Duke University Medical Center, Durham, NC.
    • Corresponding Author InformationAddress reprint requests to Lawrence B. Marks, MD, Department of Radiation Oncology, Box 3085 Duke University Medical Center, Durham, NC 27710.

References 

  1. Rust TC, Kadmas DJ. Rapid dual tracer PTSM+ATSM imaging of tumour blood flow and hypoxia: A simulation study. Phys Med Biol. 2006;51:61–75
  2. Miften MM, Das SK, Su M. Incorporation of functional imaging data in the evaluation of dose distributions using the generalized concept of equivalent uniform dose. Phys Med Biol. 2004;49:1711–1721
  3. Orlova A, Nilsson FY, Wikman M. Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors. J Nucl Med. 2006;47:512–519
  4. Nioutsikou E, Partridge M, Bedford JL. Prediction of radiation-induced normal tissue complications in radiotherapy using functional image data. Phys Med Biol. 2005;50:1035–1046
  5. Theuws JCM, Kwa SLS, Wagenar AC. Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer. Radiother Oncol. 1998;48:33–43
  6. Goethals I, Dierrckx R, De Meerleer G. The role of nuclear medicine in the prediction and detection of radiation-associated normal pulmonary and cardiac damage. J Nucl Med. 2003;44:1531–1539
  7. Tokatli F, Kaya M, Kocak Z. Sequential pulmonary effects of radiotherapy detected by functional and radiological end points in women with breast cancer. Clin Oncol. 2005;17:39–46
  8. Marks LB. The pulmonary effects of thoracic irradiation. Oncology (Huntingt). 1994;8:89–106
  9. Graham MV, Purdy JA, Emami B. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 1999;45:323–329
  10. Marks LB, Fan M, Clough R. Radiation-induced pulmonary injury: symptomatic versus subclinical endpoints. Int J Radiat Biol. 2000;76:469–475
  11. Fan M, Marks LB, Hollis D. Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction?. J Clin Oncol. 2001;19:543–550
  12. Fu X-L, Huang H, Bentel G. Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V30 and transforming growth factor β. Int J Radiat Oncol Biol Phys. 2001;50:899–908
  13. Anscher MS, Marks LB, Shafman TD. Risk of long-term complications after TGF-β1-guided very-high-dose thoracic radiotherapy. Int J Radiat Oncol Biol Phys. 2003;56:988–995
  14. Dörr W, Bertmann S, Hermann T. Radiation induced lung reactions in breast cancer therapy. Strahlenther Onkol. 2005;181:567–573
  15. Cazzaniga LF, Bossi A, Cosentino D. Radiological findings when very small lung volumes are irradiated in breast and chest wall treatment. Radiat Oncol Investig. 1998;6:58–62
  16. Kuhnt T, Richter C, Enke H. Acute radiation reaction and local control in breast cancer patients treated with postmastectomy radiotherapy. Strahlenther Onkol. 1998;174:257–261
  17. Rotstein S, Lax I, Svane G. Influence of radiation therapy on the lung-tissue in breast cancer patients: CT-assessed density changes and associated symptoms. Int J Radiat Oncol Biol Phys. 1990;18:173–180
  18. Schratter-Sehn AU, Schurawitzki H, Zach M. High-resolutioncomputed tomography of the lungs in irradiated breast cancer patients. Radiother Oncol. 1993;27:198–202
  19. Lind PA, Wennberg B, Gagliardi G. ROC curves and evaluation of radiation-induced pulmonary toxicity in breast cancer. Int J Radiat Oncol Biol Phys. 2006;64:765–770
  20. Ogasawara N, Suga K, Karino Y. Perfusion characteristics of radiation-injured lung on GD-DTPA-enhanced dynamic magnetic resonance imaging. Invest Radiol. 2002;37:448–457
  21. Fan M, Marks LB, Lind P. Relating radiation-induced regional lung injury to changes in pulmonary function tests. Int J Radiat Oncol Biol Phys. 2001;51:311–317
  22. Seppenwoolde Y, De Jaeger K, Boersma LJ. Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;60:748–758
  23. Kwa SL, Lebesque JV, Theuws JC. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys. 1998;42:1–9
  24. Lind PA, Marks LB, Hollis D. Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury. Int J Radiat Oncol Biol Phys. 2002;54:340–347
  25. Martel MK, Ten Haken RK, Hazuka MB. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys. 1994;28:575–581
  26. Oetzel D, Schraube P, Hensley F. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 1995;33:455–460
  27. Shioya S, Tsuji C, Kurita D. Early damage to lung tissue after irradiation detected by the magnetic resonance T2 relaxation time. Radiat Res. 1997;148:359–364
  28. Yankelevitz DF, Henschke CI, Batata M. Lung cancer: Evaluation with MR imaging during and after irradiation. J Thorac Imaging. 1994;9:41–46
  29. Muryama S, Akamine T, Sakai S. Risk factor of radiation pneumonitis: Assessment with velocity-encoded cine magnetic resonance imaging of pulmonary artery. J Comput Assist Tomogr. 2004;8:204–208
  30. Marks LB, Yu X, Zhou S. The impact of irradiated left-ventricular volume on the incidence of radiation-induced cardiac perfusion changes. Int J Radiat Oncol Biol Phys. 2003;57:S129
  31. Marks LB, Yu X, Prosnitz RG. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys. 2005;63:214–223
  32. Seddon B, Cook A, Gothard L. Detection of defects in myocardial perfusion imaging in patients with early breast cancer treated with radiotherapy. Radiother Oncol. 2002;64:53–63
  33. Yu X, Prosnitz RR, Zhou S. Symptomatic cardiac events following radiation therapy for left-sided breast cancer: Possible association with radiation therapy-induced changes in regional perfusion. Clin Breast Cancer. 2003;4:193–197
  34. Marks LB, Prosnitz RG, Hardenbergh PM. Functional consequences of radiation (RT)-induced perfusion changes in patients with left-sided breast cancer. Int J Radiat Oncol Biol Phys. 2002;54:S3–S4
  35. Hardenbergh PH, Munley MT, Bentel GC. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: Preliminary results. Int J Radiat Oncol Biol Phys. 2001;49:1023–1028
  36. Li D, Desphande V. Magnetic resonance imaging of coronary arteries. Top Magn Reson Imaging. 2001;12:337–347
  37. Armstrong C, Mollman J, Corn BW. Effects of radiation therapy on adult brain behavior: Evidence for a rebound phenomenon in a phase I trial. Neurology. 1993;43:1961–1965
  38. Meyers CA, Weitzner MA. Neurobehavioral functioning and quality of life in patients treated for cancer of the central nervous system. Curr Opin Oncol. 1995;7:197–200
  39. Weitzner MA, Meyers CA. Cognitive functioning and quality of life in malignant glioma patients: A review of the literature. Psychooncology. 1997;6:169–177
  40. Giovagnoli AR, Boiardi A. Cognitive impairment and quality of life in long-term survivors of malignant brain tumors. Ital J Neurol Sci. 1994;15:481–488
  41. Archibald YM, Lunn D, Ruttan LA. Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg. 1994;80:247–253
  42. Hoppe-Hirsch E, Brunet L, Laroussinie F. Intellectual outcome in children with malignant tumors of the posterior fossa: influence of the field of irradiation and quality of surgery. Childs Nerv Syst. 1995;11:340–345discussion 345-346
  43. Calvo W, Hopewell JW, Reinhold HS. Radiation induced damage in the choroid plexus of the rat brain: A histological evaluation. Neuropathol Appl Neurobiol. 1986;12:47–61
  44. Calvo W, Hopewell JW, Reinhold HS. Time- and dose-related changes in the white matter of the rat brain after single doses of X rays. Br J Radiol. 1988;61:1043–1052
  45. Devi PU, Hossain M, Bisht KS. Effect of late fetal irradiation on adult behavior of mouse: Dose-response relationship. Neurotoxicol Teratol. 1999;21:193–198
  46. Sienkiewicz ZJ, Haylock RG, Saunders RD. Prenatal irradiation and spatial memory in mice: Investigation of dose-response relationship. Int J Radiat Biol. 1994;65:611–618
  47. Sienkiewicz ZJ, Saunders RD, Butland BK. Prenatal irradiation and spatial memory in mice: Investigation of critical period. Int J Radiat Biol. 1992;62:211–219
  48. Vos MJ, Hoekstra OS, Barkhof F. Thallium-201 single photon emission computed tomography as an early predictor of outcome in recurrent glioma. J Clin Oncol. 2003;21:3559–3565
  49. Henze M, Mohammed A, Schlemmer HP. PET and SPECT for detection of tumor progression in irradiated low-grade astrocytoma: A receiver-operating characteristic analysis. J Nucl Med. 2004;45:579–586
  50. Ross DA, Sandler HM, Balter JM. Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors. J Neurooncol. 2002;56:175–181
  51. Spaeth N, Wyss MT, Weber B. Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: Implications for separation of radiation necrosis from tumor recurrence. J Nucl Med. 2004;45:1931–1938
  52. Araki Y, Imao Y, Hirata T. Cerebral blood flow of the non-affected brain in patients with malignant brain tumors as studied by SPECT with special reference to adverse effects of radiochemotherapy. No Shinkei Geka. 1990;18:601–608
  53. Harila-Saari AH, Ahonen AK, Vainionpaa LK. Brain perfusion after treatment of childhood acute lymphoblastic leukemia. J Nucl Med. 1997;38:82–88
  54. Osterlundh G, Bjure J, Lannering B. Regional cerebral blood flow and neuron-specific enolase in cerebrospinal fluid in children with acute lymphoblastic leukemia during induction treatment. J Pediatr Hematol Oncol. 1999;21:378–383
  55. Munley MT, Marks LB, Strickland JL. The effect of radiotherapy on brain metabolism using F-18 FDG PET imaging. Int J Radiat Oncol Biol Phys. 1999;45:S330–S331
  56. Kahkonen M, Metsahonkala L, Minn H. Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia. Cancer. 2000;88:693–700
  57. Hahn CA, Zhou SM, Dunn RH. Dose-dependent effects of radiation therapy on cerebral blood flow, metabolism and neurocognitive dysfunction. Int J Radiat Biol Phys. 2005;62:S67
  58. Karger CP, Münter MV, Heiland S. Dose-response curves and tolerance doses for late functional changes in the normal rat brain after stereotactic radiosurgery evaluated by magnetic resonance imaging: Influence of end points and follow-up time. Radiat Res. 2002;157:617–625
  59. Hein PA, Eskey CJ, Dunn JF. Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: Tumor recurrence versus radiation injury. Am J Neuroradiol. 2004;25:201–209
  60. Davidson A, Tait DM, Payne GS. Magnetic resonance spectroscopy in the evaluation of neurotoxicity following cranial irradiation for childhood cancer. Br J Radiol. 2000;73:421–424
  61. Virta A, Patronas N, Raman R. Spectrascopic imaging of radiation-induced effects in the white matter of glioma patients. Magn Reson Imaging. 2000;18:851–857
  62. Rango M, Spagnoli D, Tomei G. Central nervous system trans-synaptic effects of acute axonal injury: A 1H magnetic resonance spectroscopy study. Magn Reson Med. 1995;33:595–600
  63. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience. 1991;45:37–45
  64. Rutkowski T, Tarnawski R, Sokol M. 1H-MR spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors. Int J Radiat Oncol Biol Phys. 2003;56:1381–1389
  65. Usenius T, Usenius JP, Tenhunen M. Radiation-induced changes in human brain metabolites as studied by 1H nuclear magnetic resonance spectroscopy in vivo. Int J Radiat Oncol Biol Phys. 1995;33:719–724
  66. Waldrop SM, Davis PC, Padgett CA. Treatment of brain tumors in children is associated with abnormal MR spectroscopic ratios in brain tissue remote from the tumor site. AJNR Am J Neuroradiol. 1998;19:963–970
  67. Esteve F, Rubin C, Grand S. Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy. Int J Radiat Oncol Biol Phys. 1998;40:279–286
  68. Kaminaga T, Shirai K. Radiation-induced brain metabolic changes in the acute and early delayed phase detected with quantitative proton magnetic resonance spectroscopy. J Comput Assist Tomogr. 2005;29:293–297
  69. Rocca MA, Filippi M. Functional MRI to study brain plasticity in clinical neurology. Neurol Sci. 2006;27:S24–S26
  70. Di Salle F, Formisano E, Linden DE. Exploring brain function with magnetic resonance imaging. Eur J Radiol. 1999;30:84–94
  71. Moritz C, Haughton V. Functional MR imaging: paradigms for clinical preoperative mapping. Magn Reson Imaging Clin N Am. 2003;11:529–542
  72. Zou P, Mulhern RK, Butler RW. BOLD responses to visual stimulation in survivors of childhood cancer. Neuroimage. 2005;24:61–69
  73. Hakim SG, Jacobsen HC, Hermes D. Early immunohistochemical and functional markers indicating radiation damage of the parotid gland. Clin Oral Invest. 2004;8:30–35
  74. Bussels B, Maes A, Flamen P. Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer. Radiother Oncol. 2004;73:297–306
  75. Buus S, Grau C, Munk OL. 11C-methionine PET, a novel method for measuring regional salivary gland function after radiotherapy of head and neck cancer. Radiother Oncol. 2004;73:289–296
  76. Van Acker F, Flamen P, Lambin P. The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapy. Nucl Med Commun. 2001;22:225–231
  77. Nömayr A, Lell M, Sweeney R. MRI appearance of radiation-induced changes of normal cervical tissues. Eur Radiol. 2001;11:1807–1817
  78. Zhang L, Murata Y, Ishida R. Functional evaluation with intravoxel incoherent motion echo-planar MRI in irradiated salivary glands: A correlative study with salivary gland scintigraphy. J Magn Res Imaging. 2001;14:223–229
  79. Mah K, Van Dyk J, Keane T. Acute radiation-induced pulmonary damage: A clinical study on the response to fractionated radiation therapy. Int J Radiat Oncol Biol Phys. 1987;13:179–188
  80. Polansky SM, Ravin CE, Prosnitz LR. Pulmonary changes after primary irradiation for early breast carcinoma. AJR Am J Roentgenol. 1980;134:101–105
  81. Allavena C, Conroy T, Aletti P. Late cardiopulmonary toxicity after treatment for Hodgkin’s disease. Br J Cancer. 1992;65:908–912
  82. Boersma LJ, Damen EM, de Boer RW. Recovery of overall and local lung function loss 18 months after irradiation for malignant lymphoma. J Clin Oncol. 1996;14:1431–1441
  83. Theuws JC, Seppenwoolde Y, Kwa SL. Changes in local pulmonary injury up to 48 months after irradiation for lymphoma and breast cancer. Int J Radiat Oncol Biol Phys. 2000;47:1201–1208
  84. Woel RT, Munley MT, Hollis D. The time course of radiation therapy-induced reductions in regional perfusion: A prospective study with >5 years of follow-up. Int J Radiat Oncol Biol Phys. 2002;52:58–67
  85. Seppenwoolde Y, Muller SH, Theuws JC. Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2000;47:681–690
  86. Gyenes G, Fornander T, Carlens P. Morbidity of ischemic heart disease in early breast cancer 15-20 years after adjuvant radiotherapy. Int J Radiat Oncol Biol Phys. 1994;28:1235–1241
  87. Hojiris I, Sand NP, Andersen J. Myocardial perfusion imaging in breast cancer patients treated with or without post-mastectomy radiotherapy. Radiother Oncol. 2000;55:163–172
  88. Cowen D, Gonzague-Casabianca L, Brenot-Rossi I. Thallium-201 perfusion scintigraphy in the evaluation of late myocardial damage in left-side breast cancer treated with adjuvant radiotherapy. Int J Radiat Oncol Biol Phys. 1998;41:809–815
  89. Gyenes G, Fornander T, Carlens P. Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: A prospective study. Int J Radiat Oncol Biol Phys. 1996;36:899–905

 Portions of this document were adapted from Kocak Z, Marks LB: Radiation-induced lung injury, in Perez CA, Brady LW (eds): Principles and Practice of Radiation Oncology (ed 3). Philadelphia, PA: Lippincott, Williams & Wilkins, 2005 and Evans ES, Kocak Z, Zhou SM, et al: The use of radiologic imaging in the assessment of radiation-induced normal tissue injury, in Mehta MP, Paliwal BR, Bentzen SM (eds): Physical, Chemical, and Biological Targeting in Radiation Oncology. Proceedings of the 7th International Conference on Dose, Time, and Fractionation in Radiation Oncology. AAPM Symposium Proceedings No. 14. Madison, WI: Medical Physics Publishing, 2005.Supported in part by grants 17-98-1-8071 and BC010663 from the Department of Defense and NIH RO1 Grant CA69579.

PII: S1053-4296(06)00104-4

doi: 10.1016/j.semradonc.2006.11.003

Seminars in Radiation Oncology
Volume 17, Issue 2 , Pages 72-80 , April 2007

Article Tools

* Image Usage & Resolution